GlucoTrack, Inc. (GCTK)
3.05
+0.12
(+4.10%)
USD |
NASDAQ |
Sep 09, 10:55
GlucoTrack EPS Diluted (Quarterly) : -11.42 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.42 |
| March 31, 2026 | -39.69 |
| December 31, 2025 | -59.76 |
| September 30, 2025 | -69.56 |
| June 30, 2025 | -144.27 |
| March 31, 2025 | -605.24 |
| December 31, 2024 | -19575.72 |
| September 30, 2024 | -16365.96 |
| June 30, 2024 | -14756.40 |
| March 31, 2024 | -10554.30 |
| December 31, 2023 | -10390.50 |
| September 30, 2023 | -8710.20 |
| June 30, 2023 | -4908.60 |
| March 31, 2023 | -7465.50 |
| December 31, 2022 | -7477.20 |
| September 30, 2022 | -5397.30 |
| June 30, 2022 | -6554.70 |
| March 31, 2022 | -6362.10 |
| December 31, 2021 | -8771.40 |
| September 30, 2021 | -4682.70 |
| June 30, 2021 | -4972.50 |
| March 31, 2021 | -5265.00 |
| December 31, 2020 | -5124.60 |
| September 30, 2020 | -2971.80 |
| June 30, 2020 | -3346.20 |
| Date | Value |
|---|---|
| March 31, 2020 | -4726.80 |
| December 31, 2019 | -4305.60 |
| September 30, 2019 | -7195.50 |
| June 30, 2019 | -7020.00 |
| March 31, 2019 | -8318.70 |
| December 31, 2018 | -267731.0 |
| September 30, 2018 | -359693.0 |
| June 30, 2018 | -389539.7 |
| March 31, 2018 | -392640.2 |
| December 31, 2017 | -530477.8 |
| September 30, 2017 | -514565.9 |
| June 30, 2017 | -559142.8 |
| March 31, 2017 | -562173.1 |
| December 31, 2016 | -274610.6 |
| September 30, 2016 | -350999.9 |
| June 30, 2016 | -350999.9 |
| March 31, 2016 | -280799.9 |
| December 31, 2015 | -350999.9 |
| September 30, 2015 | -257399.9 |
| June 30, 2015 | -386099.9 |
| March 31, 2015 | -362699.9 |
| December 31, 2014 | -175499.9 |
| September 30, 2014 | -187199.9 |
| June 30, 2014 | 912599.7 |
| March 31, 2014 | -187199.9 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nuwellis, Inc. | -26.63 |
| Abbott Laboratories | 0.5324 |
| DexCom, Inc. | 0.6429 |
| Insulet Corp. | 1.066 |
| AngioDynamics, Inc. | -0.2735 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.814M |
| Total Expenses (Quarterly) | 3.814M |
| Enterprise Value | 2.058M |
| Earnings Yield | -5.92K% |
| Normalized Earnings Yield | -5916.57 |